Whitebox Advisors’s CERo Therapeutics Warrants CEROW Stock Holding History

Whitebox Advisors’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,250	Closed	-$309	–	525
2025 Q3	$309	Hold	23,250	–	–	﹤0.01%	427
2025 Q2	$554	Hold	23,250	–	–	﹤0.01%	382
2025 Q1	$337	Sell	23,250 -1,750	-7%	-$25	﹤0.01%	311
2024 Q4	$208	Hold	25,000	–	–	﹤0.01%	270
2024 Q3	$128	Hold	25,000	–	–	﹤0.01%	321
2024 Q2	$503	Hold	25,000	–	–	﹤0.01%	343
2024 Q1	$1.71K	Hold	25,000	–	–	﹤0.01%	298
2023 Q4	$588	Hold	25,000	–	–	﹤0.01%	309
2023 Q3	$1.79K	Hold	25,000	–	–	﹤0.01%	328
2023 Q2	$1.53K	Hold	25,000	–	–	﹤0.01%	377
2023 Q1	$1K	Hold	25,000	–	–	﹤0.01%	547
2022 Q4	$1.08K	Hold	25,000	–	–	﹤0.01%	689
2022 Q3	$2K	Hold	25,000	–	–	﹤0.01%	842
2022 Q2	$3K	Hold	25,000	–	–	﹤0.01%	821
2022 Q1	$5K	Hold	25,000	–	–	﹤0.01%	903
2021 Q4	$11K	Buy	+25,000	New	+$11.5K	﹤0.01%	796

Other funds holding CEROW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Whitebox Advisors's CEROW Position: Q4 2025 in Review

Whitebox Advisors sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 23,250 shares — an estimated $309 sold.

Whitebox Advisors first reported a position in CEROW in Q4 2021 and held it in 16 quarters. The position peaked at $11K in Q4 2021. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

Whitebox Advisors reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
Whitebox Advisors sold 23,250 CERo Therapeutics Warrants shares in Q4 2025, an estimated $309.
Whitebox Advisors first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 16 quarters.
Whitebox Advisors's CERo Therapeutics Warrants position peaked at $11K in Q4 2021.
1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Whitebox Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.